Ocugen Inc. (NASDAQ: OCGN)
$1.95
+0.0400 ( +2.09% ) 4.7M
Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").
Market Data
Open
$1.95
Previous close
$1.91
Volume
4.7M
Market cap
$501.84M
Day range
$1.88 - $1.98
52 week range
$0.35 - $2.11
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Jan 05, 2024 |
4 | Insider transactions | 1 | Jan 05, 2024 |
4 | Insider transactions | 1 | Jan 04, 2024 |
4 | Insider transactions | 1 | Jan 04, 2024 |
8-k | 8K-related | 13 | Dec 22, 2023 |
10-q | Quarterly Reports | 65 | Nov 09, 2023 |
8-k | 8K-related | 33 | Nov 09, 2023 |
8-k | 8K-related | 36 | Nov 09, 2023 |
8-k | 8K-related | 12 | Nov 02, 2023 |
8-k | 8K-related | 13 | Oct 10, 2023 |